These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1019 related items for PubMed ID: 20143151

  • 1. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [Abstract] [Full Text] [Related]

  • 2. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [Abstract] [Full Text] [Related]

  • 3. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
    Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
    [Abstract] [Full Text] [Related]

  • 4. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
    [Abstract] [Full Text] [Related]

  • 5. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
    Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
    [Abstract] [Full Text] [Related]

  • 9. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
    Yao L, Yu X, Yu L.
    Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
    [Abstract] [Full Text] [Related]

  • 10. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
    Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
    [Abstract] [Full Text] [Related]

  • 11. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
    Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, Wang JL, Wang BY, Lv FF, Wu XH, Hu LQ.
    Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
    [Abstract] [Full Text] [Related]

  • 12. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
    Lu PH, Yang J, Li C, Wei MX, Shen W, Shi LP, Jiang ZY, Zhou N, Tao GQ.
    Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
    [Abstract] [Full Text] [Related]

  • 13. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
    Ren A, Wang J.
    Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
    [Abstract] [Full Text] [Related]

  • 14. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC.
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [Abstract] [Full Text] [Related]

  • 15. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
    Yao L, Fang F, Zhong Y, Yu L.
    Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
    [Abstract] [Full Text] [Related]

  • 16. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
    [Abstract] [Full Text] [Related]

  • 17. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
    Zintzaras E.
    Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
    [Abstract] [Full Text] [Related]

  • 18. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.
    Yao L, Cao LH, Qiu LX, Yu L.
    Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of male infertility: a meta-analysis.
    Wu W, Shen O, Qin Y, Lu J, Niu X, Zhou Z, Lu C, Xia Y, Wang S, Wang X.
    Int J Androl; 2012 Feb; 35(1):18-24. PubMed ID: 21535009
    [Abstract] [Full Text] [Related]

  • 20. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J.
    Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.